Prevalence is high in southwestern Japan, the Caribbean region, West Africa, and northeast Iran, south and Central America, and there is a slight male predominance across the studies. HTLV-1 and ATL are rarely reported in North America. A recent report of ATL cases from 2001 to 2015 in North America showed an incidence rate of 0.06 per 100.000 population.